Rational malaria chemoprophylaxis - The position of primaquine. - National Genomics Data Center (CNCB-NGDC)

Advanced Search

Rational malaria chemoprophylaxis - The position of primaquine.

J Kevin Baird

Author Information

J Kevin Baird: Eijkman-Oxford Clinical Research Unit, Eijkman Institute of Molecular Biology, Jalan Diponegoro No.69, Jakarta 10430, Indonesia; Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom. Electronic address: kevin.baird@ndm.ox.ac.uk.

PMID: 28450186 DOI: 10.1016/j.tmaid.2017.04.006

No abstract text available.

N Engl J Med. 2003 Oct 16;349(16):1510-6 [PMID: 14561793]
Clin Infect Dis. 2003 Dec 15;37(12):1659-67 [PMID: 14689349]
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):79-87 [PMID: 18165478]
Clin Microbiol Rev. 2013 Jan;26(1):36-57 [PMID: 23297258]
Open Forum Infect Dis. 2014 Jun 30;1(1):ofu034 [PMID: 25734104]
PLoS Negl Trop Dis. 2015 Nov 20;9(11):e0004222 [PMID: 26587988]
Malar J. 2017 Mar 11;16(1):112 [PMID: 28284211]
Trop Dis Travel Med Vaccines. 2017 Mar 28;3:7 [PMID: 28883977]

/Wellcome Trust

Antimalarials

Chemoprevention

Drug Resistance

Humans

Malaria

Plasmodium

Primaquine

Antimalarials

Primaquine

Editorial

Synthesis, characterization, and cellular localization of a fluorescent probe of the antimalarial 8-aminoquinoline primaquine.Randomized, Double-Blind, Placebo-Controlled Studies to Assess Safety and Prophylactic Efficacy of Naphthoquine-Azithromycin Combination for Malaria Prophylaxis in Southeast Asia.Efficacy and Safety of a Naphthoquine-Azithromycin Coformulation for Malaria Prophylaxis in Southeast Asia: A Phase 3, Double-blind, Randomized, Placebo-controlled Trial.